FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017767345> ?p ?o ?g. }

• W2017767345 endingPage "121" @default.
• W2017767345 startingPage "112" @default.
• W2017767345 abstract "In a recent study we have shown that prostaglandin D2 (PGD2) induces human osteoclast (OC) apoptosis through the activation of the chemoattractant receptor homologous molecule expressed on T-helper type 2 cell (CRTH2) receptor and the intrinsic apoptotic pathway. However, the molecular mechanisms underlying this response remain elusive. The objective of this study is to investigate the intracellular signaling pathways mediating PGD2-induced OC apoptosis. OCs were generated by in vitro differentiation of human peripheral blood mononuclear cells (PBMCs), and then treated with or without the selective inhibitors of mitogen-activated protein kinase-extracellular signal-regulated kinase (ERK) kinase, (MEK)-1/2, phosphatidylinositol3-kinase (PI3K) and NF-κB/IκB kinase-2 (IKK2) prior to the treatments of PGD2 as well as its agonists and antagonists. Fluorogenic substrate assay and immunoblotting were performed to determine the caspase-3 activity and key proteins involved in Akt, ERK1/2 and NF-κB signaling pathways. Treatments with both PGD2 and a CRTH2 agonist decreased ERK1/2 (Thr202/Tyr204) and Akt (Ser473) phosphorylation, whereas both treatments increased β-arrestin-1 phosphorylation (Ser412) in the presence of naproxen, which was used to eliminate endogenous prostaglandin production. In the absence of naproxen, treatment with a CRTH2 antagonist increased both ERK1/2 and Akt phosphorylations, and reduced the phosphorylation of β-arrestin-1. Treatment of OCs with a selective MEK-1/2 inhibitor increased caspase-3 activity and OC apoptosis induced by both PGD2 and a CRTH2 agonist. Moreover, a CRTH2 antagonist diminished the selective MEK-1/2 inhibitor-induced increase in caspase-3 activity in the presence of endogenous prostaglandins. In addition, treatment of OCs with a selective PI3K inhibitor decreased ERK1/2 (Thr202/Tyr204) phosphorylation caused by PGD2, whereas increased ERK1/2 (Thr202/Tyr204) phosphorylation by a CRTH2 antagonist was attenuated with a PI3K inhibitor treatment. The DP receptor was not implicated in any of the parameters evaluated. Treatment of OCs with PGD2 as well as its receptor agonists and antagonists did not alter the phosphorylation of RelA/p65 (Ser536). Moreover, the caspase-3 activity was not altered in OCs treated with a selective IKK2/NF-κB inhibitor. In conclusion, endogenous or exogenous PGD2 induces CRTH2-dependent apoptosis in human differentiated OCs; β-arrestin-1, ERK1/2, and Akt, but not IKK2/NF-κB are probably implicated in the signaling pathways of this receptor in the model studied." @default.
• W2017767345 created "2016-06-24" @default.
• W2017767345 creator A5033125686 @default.
• W2017767345 creator A5055413476 @default.
• W2017767345 creator A5057453861 @default.
• W2017767345 creator A5070087718 @default.
• W2017767345 date "2014-03-01" @default.
• W2017767345 modified "2023-09-27" @default.
• W2017767345 title "Prostaglandin D2 induces apoptosis of human osteoclasts through ERK1/2 and Akt signaling pathways" @default.
• W2017767345 cites W1933410007 @default.
• W2017767345 cites W1943874467 @default.
• W2017767345 cites W1964174168 @default.
• W2017767345 cites W1966728300 @default.
• W2017767345 cites W1969900280 @default.
• W2017767345 cites W1971454022 @default.
• W2017767345 cites W1972605770 @default.
• W2017767345 cites W1980331332 @default.
• W2017767345 cites W1985604953 @default.
• W2017767345 cites W1985834045 @default.
• W2017767345 cites W1986543274 @default.
• W2017767345 cites W1986935281 @default.
• W2017767345 cites W1991403224 @default.
• W2017767345 cites W1991642980 @default.
• W2017767345 cites W1993755879 @default.
• W2017767345 cites W1993888258 @default.
• W2017767345 cites W1997628139 @default.
• W2017767345 cites W2010377912 @default.
• W2017767345 cites W2013937234 @default.
• W2017767345 cites W2014229794 @default.
• W2017767345 cites W2015159818 @default.
• W2017767345 cites W2017288695 @default.
• W2017767345 cites W2019320843 @default.
• W2017767345 cites W2021821328 @default.
• W2017767345 cites W2022056770 @default.
• W2017767345 cites W2026561031 @default.
• W2017767345 cites W2027872174 @default.
• W2017767345 cites W2027962131 @default.
• W2017767345 cites W2032586822 @default.
• W2017767345 cites W2033420730 @default.
• W2017767345 cites W2045100170 @default.
• W2017767345 cites W2049663776 @default.
• W2017767345 cites W2051658749 @default.
• W2017767345 cites W2054658992 @default.
• W2017767345 cites W2057219688 @default.
• W2017767345 cites W2060165569 @default.
• W2017767345 cites W2065266996 @default.
• W2017767345 cites W2068007278 @default.
• W2017767345 cites W2070088887 @default.
• W2017767345 cites W2070825285 @default.
• W2017767345 cites W2072627979 @default.
• W2017767345 cites W2073472143 @default.
• W2017767345 cites W2077779110 @default.
• W2017767345 cites W2088517480 @default.
• W2017767345 cites W2095286435 @default.
• W2017767345 cites W2097592282 @default.
• W2017767345 cites W2104879998 @default.
• W2017767345 cites W2111734580 @default.
• W2017767345 cites W2111777001 @default.
• W2017767345 cites W2114933167 @default.
• W2017767345 cites W2127114287 @default.
• W2017767345 cites W2127298694 @default.
• W2017767345 cites W2137563421 @default.
• W2017767345 cites W2140407253 @default.
• W2017767345 cites W2144957471 @default.
• W2017767345 cites W2149301267 @default.
• W2017767345 cites W2156530451 @default.
• W2017767345 cites W2157562973 @default.
• W2017767345 cites W2163870925 @default.
• W2017767345 cites W2165297525 @default.
• W2017767345 cites W2165328885 @default.
• W2017767345 cites W2166958762 @default.
• W2017767345 cites W2168961998 @default.
• W2017767345 cites W2171256006 @default.
• W2017767345 cites W2313503300 @default.
• W2017767345 doi "https://doi.org/10.1016/j.bone.2013.12.011" @default.
• W2017767345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24345643" @default.
• W2017767345 hasPublicationYear "2014" @default.
• W2017767345 type Work @default.
• W2017767345 sameAs 2017767345 @default.
• W2017767345 citedByCount "15" @default.
• W2017767345 countsByYear W20177673452014 @default.
• W2017767345 countsByYear W20177673452015 @default.
• W2017767345 countsByYear W20177673452016 @default.
• W2017767345 countsByYear W20177673452017 @default.
• W2017767345 countsByYear W20177673452018 @default.
• W2017767345 countsByYear W20177673452019 @default.
• W2017767345 countsByYear W20177673452020 @default.
• W2017767345 countsByYear W20177673452022 @default.
• W2017767345 countsByYear W20177673452023 @default.
• W2017767345 crossrefType "journal-article" @default.
• W2017767345 hasAuthorship W2017767345A5033125686 @default.
• W2017767345 hasAuthorship W2017767345A5055413476 @default.
• W2017767345 hasAuthorship W2017767345A5057453861 @default.
• W2017767345 hasAuthorship W2017767345A5070087718 @default.
• W2017767345 hasConcept C185592680 @default.
• W2017767345 hasConcept C190283241 @default.
• W2017767345 hasConcept C2777361909 @default.
• W2017767345 hasConcept C2780664492 @default.

• next